Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study

Phase 4

Completed

Conditions: A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.

Interventions: Drug: Rosuvastatin

First Posted Date: 2013-10-29

Last Posted Date: 2013-11-01

Lead Sponsor: Yonsei University

Target Recruit Count: 234

Registration Number: NCT01971606

Locations: 🇰🇷
Division of Cardiovascular Surgery, Severance Cardiovascular Hospital , Yonsei University College of Medicine, Seoul, Korea, Republic of

Association of Vitamin D, Parathyroid Hormone and Fibroblast Growth Factor-23 With Infarction-related Arrhythmia in Patients With Acute Myocardial Infarction

Conditions: Acute Myocardial Infarction

First Posted Date: 2013-10-29

Last Posted Date: 2013-10-29

Lead Sponsor: Yonsei University

Target Recruit Count: 510

Registration Number: NCT01971619

Locations: 🇰🇷
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Phase 2

Conditions: Non-small Cell Lung Cancer (NSCLC)

Interventions: Drug: LDK378

First Posted Date: 2013-10-17

Last Posted Date: 2019-01-11

Lead Sponsor: Yonsei University

Target Recruit Count: 32

Registration Number: NCT01964157

Locations: 🇰🇷
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer

Phase 2

Completed

Conditions: Thyroid Cancer

Interventions: Drug: Dovitinib

First Posted Date: 2013-10-17

Last Posted Date: 2014-12-02

Lead Sponsor: Yonsei University

Target Recruit Count: 40

Registration Number: NCT01964144

Locations: 🇰🇷
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Republic of

Lymph Node Staging System With a Novel Concept for Gastric Cancer: a Hybrid Type of Topographic and Numeric Ones

Completed

Conditions: Gastrectomy for Gastric Cancer

Interventions: Procedure: gastrectomy

First Posted Date: 2013-10-11

Last Posted Date: 2013-10-11

Lead Sponsor: Yonsei University

Target Recruit Count: 6025

Registration Number: NCT01961791

Locations: 🇰🇷
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial

Not Applicable

Completed

Conditions: Gastric Cancer
Gastric Adenoma

Interventions: Drug: Saline
Drug: Bupivacaine + saline
Drug: Bupivacaine + triamcinolone acetonide

First Posted Date: 2013-10-11

Last Posted Date: 2013-10-11

Lead Sponsor: Yonsei University

Target Recruit Count: 111

Registration Number: NCT01961752

Locations: 🇰🇷
Severnace Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery Bypass

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Dual antiplatelet therapy including aspirin and clopidogrel after off-pump coronary bypass surgery

First Posted Date: 2013-10-09

Last Posted Date: 2013-10-09

Lead Sponsor: Yonsei University

Target Recruit Count: 859

Registration Number: NCT01959191

Locations: 🇰🇷
Division of Cardiovascular Surgery, Severance Cardiovascular Hospital , Yonsei University College of Medicine, Seoul, Korea, Republic of

A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer

Phase 2

Terminated

Conditions: Advanced Gastric Cancer

Interventions: Drug: S-1 plus oxaliplatin

First Posted Date: 2013-09-19

Last Posted Date: 2016-08-19

Lead Sponsor: Yonsei University

Target Recruit Count: 3

Registration Number: NCT01946061

Locations: 🇰🇷
Severnace Hospital, Seoul, Korea, Republic of

Remote Ischemic Preconditioning Induces Myocardial RISK Signaling Pathway in Patients Undergoing Valvular Heart Surgery

Phase 4

Completed

Conditions: Patients With Elective Aortic Valve Replacement

Interventions: Procedure: Control group
Procedure: Remote ischemic preconditioning at left upper arm

First Posted Date: 2013-09-19

Last Posted Date: 2016-11-22

Lead Sponsor: Yonsei University

Target Recruit Count: 79

Registration Number: NCT01946087

Locations: 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: midazolam premedication

First Posted Date: 2013-09-18

Last Posted Date: 2014-10-07

Lead Sponsor: Yonsei University

Target Recruit Count: 82

Registration Number: NCT01945476

Locations: 🇰🇷
Department of Anesthesiology and Pain MedicineSeverance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy